medigraphic.com
ISSN 1995-9427 (Print)

2013, Number 2

<< Back Next >>

Invest Medicoquir 2013; 5 (2)

Ligation banding comebacks in pacient by esophageal varices bleeding

Chao GL, Samada SM, Barroso ML, Tusen TY, Pérez RS, Alonso SJ

Language: Spanish
References: 46
Page: 221-240
PDF size: 166.19 Kb.


ABSTRACT

Bleeding esophageal var ices is the most dreaded complication of portal hypertension and requires the completion of emergency endoscopy where the therapeutic option of choice is banding; these sets are disposable and expensive for our economic conditions. As a device for tracing the links from the original. The aim of this study was to determine the utility of the adapter created was created. A prospective descriptive study was conducted in 28 patients with bleeding esophageal varices who underwent banding with links comebacks. Ma inly males 17 (60.7%) , aged under 50 years and hepatitis C, 8 (28.5%) , when the etiology was related to the degree of hepatic impairment there was a tendency for the hepatitis C patients show a higher degree of hepatic impairment Child B 3 (37.5%) and C5 (62.5%). More sessions ligation was required in patients with major hepatic impairment (Child C 5 and 6 sessions.) Complications occurred in 6 patients (21.4%). The overall recurrence rate was 7.14%. It was concluded that the adapter trace leagues, is an alternative for patients requiring ligation of esophageal varices.


REFERENCES

  1. Mortalidad. En: Bess Constantén S, editor. Anuario estadístico de salud 20 10. La Habana: Dirección nacional de registros médicos y estadísticas de salud del Ministerio de Salud Pública; 2013. p. 27 -83.

  2. Pagliaro L, D’Amico G, Pasta L, Politi F, Vizzini G, et al. Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann RJ.Portal Hypertension. Pathophysiology and Treatment. Oxford, UK: Blackwell Scientific; 1994. p . 72- 92.

  3. D´Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta - analytic review. Hepatology 1995;22:332.

  4. Albillos A, Ruiz del Árbol L. Tratamiento de la hipertensión portal. Rev Clin Esp 2001;201:528-38.

  5. Bosch J, Albillos A, Abraldes JG, Bañares R, Calleja JL, et al. Hipertensión portal. Documento de consenso . Gastroenterol Hepatol 2005;28: 1-25.

  6. Kleber G, Sauerbruch T, Ansari H, Paumg artner G. Prediction of v ariceal hemorrhage in cirrhosis : a prospective folow -up study. Gastroenterology 1991;100:1332-37.

  7. Beppu K, Inokuchi K, Koyanagi N . Predictionof variceal hemorrhage by oesophageal endosco py.Gastrointest Endosc 1981;27: 213-8.

  8. The North Italian Endoscopic Club for the Study andTreatment of Esophageal Várices. Prediction of thefirst variceal hemorrhage in patients with cirrhosisof the liver and esophageal várices: a prospectivemulticenter study. N Engl J Med 1988;319:983-9.

  9. Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding unresolved issues: summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single - topic conference. Hepatology 2008;47:1764-72

  10. Groszmann RJ, Garcia -Tsao G, Bosch J, Grace ND, Burroughs AK , et al. For the Portal Hypertension Collaborative Group. Beta -Blockers to Prevent GastroesophagealVarices in Patients with Cirrho sis. N Engl J Med 2005;353:2254-61.

  11. Merli M, Nicolini G, Angeloni S, Rinaldi V, De SA, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol 2003;38:266 - 72.

  12. Alcantara RV, Yamada RM, De Tommaso AM, Bellomo -Brandão MA, Hessel G. Non-invasive predictors of esophageous v arices in children and adolescents with chronic liver disease or extrahepatic portal venous obstruction. J Pediatr 2012;88:341-6.

  13. Pagliaro L, D'Amico G, So rensen TIA, Lebrec D, Burroughs AK, et al. Prevention of first bleeding in cirrhosis. A meta -analysis of randomized trials of nonsurgical treatments. Ann Int Med 1992;117:59 -70.

  14. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-09.

  15. Loffroy R, Estivalet L, Cherblanc V, Favelier S, Pottecher P, et al. Trans jugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage. World J Gastroenterol 2013;7(19) :6131-6143.

  16. Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.World J Gastroenterol 2013;21(19):5035-50.

  17. Ríos E, Sierralta A, Abarzúa M, Bastías J, Barra MI. Comparison of band ligation with sclerotherapy for the treatment of bleeding esophageal varices.Rev Med Chil. 2012;140:713-8

  18. Poza Cordon J, Froilan Torres C, Burgos García A, Gea Rodr iguez F, Suárez de Parga JM. Endoscopic management of esophageal varices. World J Gastrointest Endosc 2012;16(4):312 -22.

  19. Cárdenas A. Management of acute variceal bleeding: emphasis on endoscopic therapy. Clin Liver Dis 2010;14(2):251 -62.

  20. Steigmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527 -32.

  21. Lahbabi M, Mellouki I, Aqodad N, Elabkari M, Elyousfi M, et al. Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up Pan. Afr Med J 2013;10(14):95-8.

  22. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment ofesophageal variceal bleeding. A metaanalysis. Ann Intern Med 1995;123:280- 87.

  23. Ji JS, Cho YS. Endoscopic band ligation: beyond prevention and management of gastroesophageal varices. World J Gastroenterol 2013;19(27):4271 -6

  24. A Lyles T, Elliott A, Rockey DC. Risk Scoring System to Predict In -hospital Mortality in Patients with Cirrhosis Presenting with Upper Gastrointestinal Bleeding. Clin Gastroenterol 2013;28: 201-17.

  25. Thiele M, Krag A, Rohde U, Gluud LL. Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oes ophageal varices. Aliment Pharmacol Ther 2012;35:1155 -65.

  26. Bhuiyan MM, Rahman MM, Kibria MG, Hasan M. Comparative study of endoscopic band ligation and sclerotherapy for treatment of oesophageal varices in cirrhotic patients. Bangladesh Med Res Counc Bull 2007;33:31-9.

  27. Infante M, Fuentes M, Pérez M, Ramos Y, Winograd R, et al. Ligadura endoscópica de várices esofágicas más propranolol para profilaxis secundaria del sangrado digestivo en pacientes cirróticos. Rev Cubana Med Mil [revista en la Internet]. 2013 Mar [citado 2013 Oct 27] ; 42(1): 39 -48. Disponible en: URL: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138 - 65572013000100006&lng=es

  28. Samada M, Hernández JC, Barroso L, Chao L, González M, et al. Identificación de factores de riesgo de presencia de várices esofágicas en pacientes con cirrosis hepática. Rev Cub Med Mil [revista en la Internet]. 2008 Mar [citado 2013 Oct 27]; 37(1): Dispon ible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138 - 65572008000100002&lng=es

  29. Dehesa-Violante M, Nuñez-Nateras R. Epidemiology of Hepatit is Virus B and C. Archives of Medical Research 2007; 38:606-11.

  30. Naveau S, Perlemuter G, Balian A. Epidemiology and natural hist ory of cirrhosis.Rev Prat 2005; 55(14):1527-32.

  31. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, et al. The Importance of HCV on the Burden of Chronic Liver Disease in Italy: A Multicenter Prevalence Study of 9,997 Cases. Journal of Medical Virology 2005;75:522 –27.

  32. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, et al. The Prevalence of Hepatitis C Virus Infectio n in the United States, 1999 through 2002. Ann Intern Med 2006;144:705 -14.

  33. Simón Marco MA. Consenso para el tratamiento de las hepatitis B y C. Virus de la hepatitis B. Historia natu ral. Gastroenterol Hepatol 2006; 29:101-06.

  34. Fattovich G, Bortolotti F, Dona to F. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. Journal of Hepatology 2008;48:335 –52.

  35. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, et al. The Importance of HCV on the Burden of Chron ic Liver Disease in Italy: A Multicenter Prevalence Study of 9,997 Cases. Journal of Medical Virology 2005;75:522 –27.

  36. Said A, Williams J, Holden J, Remington P, Gangnon R, et al. Model for end stage liver disease score predicts mortality across a broad spe ctrum of liver disease. J Hepatol 2004;40:897 –03.

  37. Wiesner RH, Edwards E, Freeman R, Harper A, Kim R, et al. Model for end -stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-6.

  38. Samada M. Factores pronósticos de supervive ncia en pacientes con cirrosis hepática evaluados para trasplant e hepático [tesis]. La Habana: Centro de Investigaciones Médico-Quirúrgicas; 2008.

  39. D’Amico G, De Franchis R. Upperdigestive bleeding in cirrhosis. Post Gastroenterol latinoam 2012;23(4):229 -32.

  40. Harewood GC, Baron TH, Song LM. Factors predicting success of endoscopic variceal ligation for secondary prophylaxis of esophageal variceal bleeding (II). J Gastroenterol Hepatol 2006;21(1):237 -41.

  41. Salazar P, González JC, Louis C. Ligaduras de Várices Esofágicas: Alcance del Procedimiento. AVFT [revista en la Internet]. 2002 Jul [citado 2013 Nov 16]; 21(2): 190-194. Disponible en: URL: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0798 - 02642002000200010&lng=es

  42. Xu L, Ji F, Xu QW, Zhang MQ. Risk factors for predicting early variceal rebleeding after endoscopic variceal ligation. World J Gastroenterol 2011;17:3347-52.

  43. Grothaus J, Petrasc h F, Zeynalova S, Mössner J, Schiefke I, et al. Risk factors for bleeding complications after endoscopic variceal ligation therapy. Z Gastroenterol 2010;48:1200 -6.

  44. Higón Ballester A, Siles Moreno S, Gálvez Castillo C, Bustamante Balén M , Ligadura con bandas elásticas de varices esófago -gástricas en el Area 10. Nuestra experiencia. Rev Soc Valencia Patol Dig 2001;20:114.

  45. Petrasch F, Grothaus J, Mossner J, Schiefke I, Hoffmeister A. Differences in bleeding behavior after endoscopic band ligation: a retrospect ive analysis. BMC Gastroenterol 2010;10:5 -8.

  46. Turon F, Casu S, Hernández -Gea V, Garcia-Pagán JC. Variceal and other portal hypertension related bleeding. Best Pract Res Clin Gastroenterol 2013;27:649 - 64.




2020     |     www.medigraphic.com